awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37178611-7F45FB4E-41F6-4461-8DA5-FC840614A178
Q37178611-7F45FB4E-41F6-4461-8DA5-FC840614A178
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37178611-7F45FB4E-41F6-4461-8DA5-FC840614A178
Treatment challenges in the management of relapsed or refractory non-Hodgkin's lymphoma - novel and emerging therapies.
P2860
Q37178611-7F45FB4E-41F6-4461-8DA5-FC840614A178
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37178611-7F45FB4E-41F6-4461-8DA5-FC840614A178
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a790e6994ecd06aeac2bf67e0809c45271155884
P2860
Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma.